Circulating extracellular vesicles carrying Firmicutes reflective of the local immune status may predict clinical response to pembrolizumab in urothelial carcinoma patients.
Jingushi K, Kawashima A, Saito T, Kanazawa T, Motooka D, Kimura T, Mita M, Yamamoto A, Uemura T, Yamamichi G, Okada K, Tomiyama E, Koh Y, Matsushita M, Kato T, Hatano K, Uemura M, Tsujikawa K, Wada H, Nonomura N.
Jingushi K, et al. Among authors: nonomura n.
Cancer Immunol Immunother. 2022 Dec;71(12):2999-3011. doi: 10.1007/s00262-022-03213-5. Epub 2022 May 22.
Cancer Immunol Immunother. 2022.
PMID: 35598195
Free PMC article.